The regulation of human genetics by international soft law and international trade

Genetic Engineering and the World Trade System: World Trade Forum

Volumn , Issue , 2008, Pages 315-342

  El Zein, Souheil ^a  

^a UNITED NATIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860184899     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511494581.013     Document Type: Chapter

References (8)

1. A. Buchanan et al., From Chance to Choice: Genetics and Justice (New York: Cambridge University Press, 2000)
2. A. Dinnyes, P. de Sousa, T. King and I. Wilmut, ‘Somatic Cell Nuclear Transfer: Recent Progress and Challenges’ (2002) 4 Cloning and Stem Cells 81
3. C. E. Marilyne, ‘Therapeutic Cloning: From Consequences to Contradiction’ (2002) 27 Journal of Medicine and Philosophy 297–317.
4. Abdulqawi Yusuf, ‘The UN Convention on Biological Diversity’, in N. Al-Nauimi and R. Meese (eds.), International Legal Issues Arising under the United Nations Decade of International Law (The Hague: Kluwer Law International, 1995), pp. 1163–95.
5. R. Brownsword. ‘Stem Cells and Cloning: Where the Regulatory Consensus Fails’ (2005) 39 New England Law Review 535.
6. Deryck Beyleveld and Roger Brownsword, Human Dignity in Bioethics and Biolaw. (Oxford: Oxford University Press, 2001).
7. Tom Wilkie, ‘Whose Gene Is It Anyway?’, The Independent, 19 November 1995.
8. J. P.H., Chipaux, ‘I’Afrique, cobaye de big pharma: medicaments sans scrupules’, Le Monde Diplomatique, June 2005.